Back to search
FDAFDA · Food and drugs·Recall number D-0239-2026

Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred Pharmaceuticals NDC 68788-8666-01

Published December 24, 2025 · Recall initiated: November 17, 2025

Summary

FDA records drug Class II recall D-0239-2026, published December 24, 2025 and initiated November 17, 2025. Recalling firm: Preferred Pharmaceuticals, Inc.; Status: Ongoing; Reported quantity: 575 1x10 Foil Blister Packs; Lot: Lot: J1325J, I1725P, EXP Date: 4/30/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Preferred Pharmaceuticals, Inc.
Distributor
Natinowide in the USA
Lot
Lot: J1325J, I1725P, EXP Date: 4/30/2027.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred Pharmaceuticals NDC 68788-8666-01 recalled?

Yes. FDA published recall D-0239-2026 on December 24, 2025. Reported hazard: Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.

What should I do if I have this product?

Voluntary: Firm initiated · Letter